Women’s Health Awareness Month: The Evolving Women’s Health Clinical Development Landscape

Life Sciences, Clinical Trials, Patient Recruitment & Retention,
  • Tuesday, May 28, 2024

Learn from industry experts about the dynamic landscape of clinical development related to Women’s Health and obtain key insights into its unique medical and operational aspects. Right from study design and site selection to recruitment, retention and operational strategies, this webinar will provide actionable insights that can drive impactful research outcomes.

May is recognized as National Women’s Health Awareness Month, highlighting the unique challenges and disparities that women face globally in healthcare. Despite comprising around half of the world’s population, women have historically been understudied and underrepresented in clinical research, leading to significant gaps in knowledge and treatment options.

However, amidst the recent biotech slowdown, clinical development related to Women’s Health has garnered increasing attention in recent years. Venture capital funding for Women’s Health is increasing, driven by US Food and Drug Administration (FDA) and White House initiatives focused on research related to Women’s Health.

The expert panel will explore the past, present and future of Women’s Health clinical research, addressing common misconceptions and highlighting significant opportunities for investment and innovation. The discussion will span the entire spectrum of women’s health needs across the life cycle, ranging from adolescent to post-menopausal gynecologic needs.

Do not miss the opportunity to gain expert guidance and contribute to the advancement of clinical development related to Women’s Health on a global scale. Register now and help in shaping the future of healthcare for women worldwide.


Dr. Jaclyn Jansen, MD, MS, Medical Director, Medical Department, General Medicine, Medpace (Webinar Moderator)

Dr. Jaclyn Jansen is a board-certified Emergency Medicine Physician with six years of experience in clinical emergency medicine and a decade in post-graduate research. She was the visionary founder of the EM Women’s Residency Mentoring Program at IUSOM and served as the Emergency Medicine resident representative for the IU Health Patient Experience Review Council.

Dr. Jansen’s leadership is evident in her role as the driving force behind a GME-approved initiative of implementing preferential pregnancy scheduling policies across residency programs at her home institution.

Her dedication to advancing medical knowledge and advocacy for women is reflected in her numerous peer-reviewed publications, particularly in emergency medicine and protective policies for residents in family planning. Recognized for her outstanding impact, Dr. Jansen is the proud recipient of the Residency Impact Award for Mentoring.

Message Presenter
Dr. Aparna D. Shah, Medpace

Dr. Aparna D. Shah, MD, FACOG, Medical Director, Medical Department, Women’s Health, Medpace

Dr. Aparna D. Shah is board-certified by the American Board of Obstetrics and Gynecology in Obstetrics and Gynecology as well as in Urogynecology and Reconstructive Pelvic Surgery. Dr. Shah earned her medical degree from the University of Michigan Medical School and brings over 20 years of experience in Women’s Health-focused research, academia and clinical care. She completed her residency in Obstetrics and Gynecology at Brigham and Women’s and Massachusetts General Hospitals, followed by a clinical and research fellowship in Urogynecology and Reconstructive Pelvic Surgery at Brigham and Women’s Hospital.


Recognized as a “Future Leader in Obstetrics and Gynecology” by the American College of Obstetricians and Gynecologists, Dr. Shah received the “Organon Resident Research Award for Outstanding Research in Women’s Health”. Subsequent to her training, Dr. Shah completed the Program in Clinical Effectiveness through the Harvard School of Public Health.

Dr. Shah has published multiple peer-reviewed papers on an array of Women’s Health topics, and has practiced Gynecology and Urogynecology in multi-specialty and academic practices, providing inpatient, outpatient and consultative care. Dr. Shah has broad clinical experience in diagnosing and treating a wide variety of Women’s Health conditions, and is well-versed in the execution of Women’s Health focused clinical trials.

Read Less...

Message Presenter
Dr. Rujin Ju, Medpace

Dr. Rujin Ju, MD, MSCR, FACOG, Medical Director, Medical Department, Women’s Health, Medpace

Dr. Rujin Ju is a Urogynecologist, bringing over 12 years of post-graduate clinical and research experience in Obstetrics and Gynecology. Graduating from the Albert Einstein College of Medicine, Dr. Ju completed her Obstetrics and Gynecology residency at Mount Sinai Hospital-Beth Israel before pursing an NIH clinical fellowship in Epidemiology and Clinical Trials.


Concurrently, she obtained her master’s degree in clinical research from the University of North Carolina at Chapel Hill, Gillings School of Public Health. Dr. Ju served on the faculty at Columbia University as an Assistant Clinical Professor in the Department of Obstetrics and Gynecology before the completion of fellowship training in Urogynecology and Reconstructive Pelvic Surgery at Indiana University.

Her extensive experience spans clinical practice and clinical research across private, multi-specialty, and academic settings, encompassing inpatient, outpatient, surgical and consultative care. Dr. Ju has made notable contributions to the fields of Gynecology, Urogynecology and surgical education through her published manuscripts.

Read Less...

Message Presenter
Beth Tulip, Medpace

Beth Tulip, Senior Executive Director, Clinical Trial Management, Medpace

Beth Tulip is a Senior Executive Director of Clinical Trial Management with over 25 years of clinical research experience in the CRO industry. With an established track record of developing and implementing innovative, strategic solutions, Beth consistently optimizes trial performance throughout Phase I-IV of the drug development life cycle.

Her expertise spans Infectious Diseases, Vaccines, Women’s Health and Pediatrics, making her a recognized leader in the clinical development industry. Beth’s contributions have been instrumental in obtaining FDA approval for 23 medicinal products for Women’s Health, Infectious Diseases and Vaccines.

Message Presenter

Who Should Attend?

This webinar will appeal to CEOs, VPs, Directors, Managers and Department Heads working within:

  • Clinical Affairs
  • Clinical Research
  • Clinical Outsourcing
  • Project Management
  • Regulatory Affairs
  • Medical Affairs

What You Will Learn

Attendees will learn about the following as it relates to Women’s Health clinical development:

  • The underrepresentation and underfunding of Women’s Health research, and how the landscape has evolved over time
  • Opportunities for clinical innovation beyond traditional focus areas as panelists uncover the diverse spectrum of women’s healthcare needs
  • Actionable insights and strategies in study design, site selection, recruitment, retention and the integration of cutting-edge technologies

Xtalks Partner


Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account